Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Absorption-Distribution-Metabolism-Excretion Toxicity
25%
Anethole
33%
Annona squamosa
50%
baker's yeast
50%
Bioavailability
17%
Breast Cancer
75%
Burn
50%
Carboxylate
16%
Carnitine
50%
Cheilocostus speciosus
25%
Cyclopentane
33%
Cytotoxin
50%
Epidermal Growth Factor Receptor
16%
Free Radical
16%
Gelatinase B
50%
Glutathione
16%
Gymnema sylvestre
50%
IC50
33%
Inflammation
16%
Isoeugenol
25%
Lactobacillus acidophilus
50%
Lapatinib
50%
Letrozole
25%
Liver Cancer
50%
Lung Cancer
25%
Malignant Neoplasm
76%
Metralindole
50%
Mouse Model
100%
Neoplasm
50%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
16%
Norovirus
50%
Phosphonate
16%
Phosphonium
16%
Phosphotransferase
16%
Phytochemical
25%
Proteinase
100%
Restriction Endonuclease
25%
RNA 16S
26%
Rubia cordifolia
50%
Sacituzumab Govitecan
16%
Saponin
50%
Serine Proteinase
57%
Side Effect
21%
Siloxane
16%
Silver Nanoparticle
50%
Silver Sulfadiazine
28%
Sphingosine Kinase 1
25%
Sweet orange
16%
Target Identification
16%
Tumor Necrosis Factor
16%
Biochemistry, Genetics and Molecular Biology
Absorption
16%
Adaptive Behavior
12%
ADMET
50%
Aeromonas hydrophila
50%
Anethole
50%
Annona squamosa
50%
Annonaceae
25%
Anticancer
75%
Antidiabetic Activity
12%
Antiinflammatory Activity
12%
Binding Affinity
41%
Binding Energy
25%
Cancer Cell
20%
Cheilocostus speciosus
50%
Cnicus
50%
Cyclin-Dependent Kinase 2
25%
Cytotoxicity
29%
Docking (Molecular)
66%
Doxorubicin
25%
Energy Landscape
25%
Epidermal Growth Factor Receptor
25%
Extract
37%
Fibroblast Growth Factor Receptor 1
25%
Gene Expression
25%
Helicobacter pylori
25%
Immune-Related Gene
50%
In Silico Study
25%
Intellectual Disability
25%
Kinase
25%
Medicinal Plant
12%
Methyltransferase
50%
Norovirus
50%
Oreochromis niloticus
50%
Pharmacokinetic
20%
Phosphotransferase
25%
Phytochemical
12%
Phytochemical Analysis
25%
Programmed Cell Death
12%
Protease
50%
Proteomics
35%
Reprogramming
20%
Serine Protease
50%
Signaling Protein
50%
Sorafenib
14%
Staurosporine
25%
Stromal Cell
20%
Survival Rate
25%
Tamsulosin
50%
Targeted Therapy
12%
Transfer RNA
50%
Medicine and Dentistry
Antibody Specificity
16%
Antineoplastic Activity
8%
Antiviral Drug
8%
Artificial Intelligence
8%
Bacillus subtilis
25%
Binding Affinity
13%
Binding Energy
11%
Breast Cancer
75%
Cancer Therapy
15%
Casein Kinase II
12%
Cyclin-Dependent Kinase 2
12%
Cytotoxin
25%
Debridement
25%
Dermis
7%
Division
25%
Docking (Molecular)
32%
Drug Resistance
8%
Energy Transfer
7%
Eschar
50%
Five-Year Survival Rate
12%
Holoenzyme
12%
Host Cell
11%
In Vitro
14%
Kinase
50%
Liver Tissue
50%
Lung Cancer
25%
Metralindole
50%
Nandrolone
40%
Nandrolone Decanoate
50%
Natural Product
64%
Non-Small Cell Lung Cancer
12%
Norovirus
50%
Norovirus Infection
8%
PARP Inhibitor
16%
Precision Oncology
8%
Proteinase
75%
Proteinase Inhibitor
16%
Sacituzumab Govitecan
16%
Side Effect
20%
Sinusoid
20%
Sorafenib
16%
Staurosporine
12%
Sulfadiazine Silver
14%
Target Identification
16%
Targeted Therapy
7%
Thermal Burn
25%
Tumour Heterogeneity
8%
Vacuolization
10%
Virtual Screening
50%
Whey Protein
50%
